An overview of the clinical management and challenges of treatments for the patients diagnosed with COVID-19 and lung carcinoma
This thesis is submitted in partial fulfillment of the requirements for the degree of Bachelor of Pharmacy, 2021.
Huvudupphovsman: | Bristy, Israt Zerin |
---|---|
Övriga upphovsmän: | Kabir, Md. Tanvir |
Materialtyp: | Lärdomsprov |
Språk: | English |
Publicerad: |
Brac University
2021
|
Ämnen: | |
Länkar: | http://hdl.handle.net/10361/15619 |
Liknande verk
-
Molecules associated with the development of lung cancer
av: Rahman, Adree, et al.
Publicerad: (2023) -
A case study of lung cancer patients in term of various risk factors in context of Bangladesh
av: Shabnam, Musharrat
Publicerad: (2018) -
Immunotherapy in the Management of Lung Cancer
av: Tasnim, Humayra
Publicerad: (2022) -
Effect of performance status on efficacy endpoints in phase II trials of non-small cell lung cancer
av: Paul, Pulock
Publicerad: (2024) -
Potential of liposomes for the treatment of lung cancer- a review
av: Mim, Shanzida
Publicerad: (2023)